Introduction {#sec1}
============

Pyrrole derivatives that contain chiral centers are prevalent moieties in many natural products and active pharmaceuticals.^[@ref1]^ Because the biological activities are strongly linked with stereochemistry, the catalytic asymmetric reaction remains a topic of ongoing research in synthetic organic chemistry. As a type of this reaction, Friedel--Crafts alkylation of pyrrole has emerged as an important synthetic strategy for the construction of stereogenic carbon centers.^[@ref2]^ For instance, the organocatalyzed Friedel--Crafts alkylation of pyrroles was reported by Paras and MacMillan^[@cit3a]^ and Enders et al.^[@cit3b]^ Later, enantioselective Friedel--Crafts alkylation catalyzed by metal complexes was developed greatly in the past few decades.^[@ref4]^ Palomo et al.,^[@cit5a]^ Arai et al.,^[@cit5b]^ Fu et al.,^[@cit5c]^ and George and Reddy^[@cit5d]^ developed enantioselective Friedel--Crafts alkylation of pyrroles catalyzed by copper complexes. Recently, Evans and Fandrick^[@cit6a]^ and Feng et al.^[@cit6b]^ disclosed similar reactions with scandium complexes. Very recently, the Friedel--Crafts alkylation of pyrroles catalyzed by zinc complexes was reported by Singh and Singh^[@cit7a]^ and Chang et al.^[@cit7b]^ However, all of these Friedel--Crafts alkylations mentioned above were carried out in organic solvents. The asymmetric Friedel--Crafts alkylation of pyrroles in water is rarely reported.

Compared with the organic solvents, water is a safe, harmless, cheap, facile, and environmentally benign medium.^[@ref8]^ Carried out in aqueous media, the reactions can avoid the tedious protection and deprotection for those sensitive groups under an organic solvent, such as hydroxyl, carboxylic, amino, and sulfhydryl groups. Besides, the reactions in water do not need multifarious manipulation, such as degas and inert gas filling. Constructing a chiral center by virtue of Friedel--Crafts alkylation in aqueous media is still a challenge for organic synthesis. Our group has been focusing on the asymmetric organic reaction in water for a long time, and many water-chiral catalysts were synthesized and investigated.^[@ref9]^ As our continuing interest, we herein report our recent efforts in developing enantioselective Friedel--Crafts alkylation of pyrrole with 2-enoyl-pyridine *N*-oxides in aqueous media ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![Study on the Enantioselective Friedel--Crafts Alkylation of Pyrrole with 2-Enoyl-pyridine *N*-Oxides](ao9b04115_0008){#sch1}

Results and Discussion {#sec2}
======================

Our investigation began with the reaction of 2-enoyl-pyridine *N*-oxide **1a** and pyrrole **2** in water/chloroform (10:1) ([Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}). First of all, the Schiff base ligand **L1** was employed with various metal salts at 0 °C for this reaction. To our delight, Zn(OTf)~2~ could perform well to afford the target product **3a** with high yield and good enantioselectivity, while the other metal salts gave poor results ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 1--9). Subsequently, ligand **L2** was investigated in this reaction, and the target product **3a** was obtained with good yield but lower ee value ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 2 and 10). To further optimize the reaction conditions, ligand **L1** was chosen as the optimal ligand and different temperatures were examined. Raising the temperature resulted in the decrease in the ee values despite a few increases in reaction yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 11 and 12). To increase the solubility of the reactants in water, various kinds of solvents were added to the reaction mixture. It was found that 1.0 mL of H~2~O containing 0.1 mL of CHCl~3~ was the best choice ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 1--5). To further enhance the stereoselectivity of this reaction, different phase transfer catalysts (PTCs) and weak base additives were examined ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 6--8). PTCs had a negative effect on the reaction, while weak base additives could enhance the stereoselectivity ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries 6--16). Especially, the use of piperidine gave the target product **3a** in 92% yield with 96% ee ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry 10). After investigation, the optimal conditions were decided as below: Zn(OTf)~2~ with the chiral ligand **L1** as the catalyst, piperidine as the additive, and the reaction being carried out in an aqueous medium at 0 °C.

###### Optimization of the Ligands, Temperatures, and Metal Salts of the Reaction[a](#t1fn1){ref-type="table-fn"}

![](ao9b04115_0004){#gr5}

  entry   ligand   temperature (°C)   metal salt       yield[b](#t1fn2){ref-type="table-fn"} (%)   ee[c](#t1fn3){ref-type="table-fn"} (%)
  ------- -------- ------------------ ---------------- ------------------------------------------- ----------------------------------------
  1       **L1**   0                  Cu(OTf)~2~       75                                          5
  2       **L1**   0                  Zn(OTf)~2~       84                                          86
  3       **L1**   0                  Sc(OTf)~3~       43                                          2
  4       **L1**   0                  CrCl~3~          trace                                        
  5       **L1**   0                  FeSO~4~·7H~2~O   trace                                        
  6       **L1**   0                  CoCl~2~·6H~2~O   56                                          58
  7       **L1**   0                  NiSO~4~·7H~2~O   trace                                        
  8       **L1**   0                  ZnBr~2~          76                                          73
  9       **L1**   0                  Zn(NO~3~)~2~     84                                          77
  10      **L2**   0                  Zn(OTf)~2~       83                                          81
  11      **L1**   10                 Zn(OTf)~2~       89                                          84
  12      **L1**   25                 Zn(OTf)~2~       91                                          82

Unless otherwise noted, the reactions of **1a** (0.1 mmol) and **2** (0.3 mmol) were performed in the presence of ligand (10 mol %) and metal salt (10 mol %) in H~2~O/CHCl~3~ (1.0/0.1 mL) at the temperature indicated for 24 h.

Isolated yields.

Determined by chiral HPLC analysis. Tf, trifluoromethanesulfonyl.

###### Optimization of the Solvents, PTCs, and Bases of the Reaction[a](#t2fn1){ref-type="table-fn"}

![](ao9b04115_0003){#gr6}

  entry   solvent            PTC           base         yield[b](#t2fn2){ref-type="table-fn"} (%)   ee[c](#t2fn3){ref-type="table-fn"} (%)
  ------- ------------------ ------------- ------------ ------------------------------------------- ----------------------------------------
  1       H~2~O/CHCl~3~                                 84                                          86
  2       H~2~O                                         52                                          56
  3       H~2~O/toluene                                 86                                          84
  4       H~2~O/CH~2~Cl~2~                              84                                          79
  5       H~2~O/MeOH                                    74                                          51
  6       H~2~O/CHCl~3~      Bu~4~NBr                   87                                          84
  7       H~2~O/CHCl~3~      Bu~4~NPF~6~                91                                          82
  8       H~2~O/CHCl~3~      SDS                        80                                          81
  9       H~2~O/CHCl~3~                    NEt~3~       87                                          89
  10      H~2~O/CHCl~3~                    piperidine   92                                          96
  11      H~2~O/CHCl~3~                    DBU          88                                          94
  12      H~2~O/CHCl~3~                    Na~2~CO~3~   83                                          90
  13      H~2~O/CHCl~3~                    Cs~2~CO~3~   79                                          92
  14      H~2~O/CHCl~3~      Bu~4~NBr      piperidine   93                                          81
  15      H~2~O/CHCl~3~      Bu~4~NPF~6~   piperidine   97                                          91
  16      H~2~O/CHCl~3~      SDS           piperidine   84                                          91

Unless otherwise noted, the reactions of **1a** (0.1 mmol) and **2** (0.3 mmol) were performed in the presence of **L1** (10 mol %), Zn(OTf)~2~ (10 mol %), PTC (10 mol %), and base (10 mol %) in solvent (1.0/0.1 mL) at 0 °C for 24 h.

Isolated yields.

Determined by chiral HPLC analysis. SDS, sodium dodecyl sulfate.

With the optimal conditions in hand, the substrate scope of 2-enoyl-pyridine *N*-oxides **1** was studied ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Initially, the electronic effect of the substrates was investigated by varying the *para*-substituent groups of R. It was found that the substrates with electron-donating groups in the *para*-position of the phenyl ring gave the desired products with high yields and excellent enantioselectivities (entries 2 and 3). Meanwhile, the substrates bearing electron-withdrawing halogen groups in the *para*-position of the phenyl ring led to almost no change in the yield and ee value (entries 4--6). With the exchange of halogen groups to strong electron-withdrawing trifluoromethyl group, excellent enantioselectivity of the Friedel--Crafts adducts could be maintained, albeit with a slight erosion of yield (entry 7). As for the substrate **1h**, bearing a nitro group on the phenyl ring also worked well in the reaction (entry 8). Afterward, different positions for the substituents of R were investigated. The products bearing *para*- and *meta*-substituents could be obtained in high yields and excellent enantioselectivities (entries 2--11). However, when the sterically encumbered *ortho*-substituent was employed, a trace of the corresponding product **3l** was detected, which indicated that hindrance had a great negative influence on the reaction (entry 12). On the other hand, a multisubstituted group could also be compatible, affording products **3m** with excellent enantioselectivity (\>99% ee). More importantly, the naphthalene substrate **1n**, the thiophene substrate **1o**, and the furan substrate **1p** could also be converted into interesting products **3n**--**3p** with high yields and excellent enantioselectivities (entries 14--16). In addition, the absolute configuration of the product **3** was confirmed through HPLC data and specific rotation data.^[@cit7a]^

###### Scope of 2-Enoyl-pyridine *N*-Oxides[a](#t3fn1){ref-type="table-fn"}

![](ao9b04115_0002){#gr7}

  entry   R (**1**)                       **3**    time[b](#t3fn2){ref-type="table-fn"} (h)   yield[c](#t3fn3){ref-type="table-fn"} (%)   ee[d](#t3fn4){ref-type="table-fn"} (%)
  ------- ------------------------------- -------- ------------------------------------------ ------------------------------------------- ----------------------------------------
  1       Ph (**1a**)                     **3a**   24                                         92                                          96
  2       *p*-MeC~6~H~5~ (**1b**)         **3b**   48                                         90                                          94
  3       *p*-MeOC~6~H~5~ (**1c**)        **3c**   48                                         84                                          98
  4       *p*-FC~6~H~5~ (**1d**)          **3d**   30                                         95                                          97
  5       *p-*ClC~6~H~5~ (**1e**)         **3e**   24                                         88                                          93
  6       *p*-BrC~6~H~5~ (**1f**)         **3f**   24                                         92                                          \>99
  7       *p*-CF~3~C~6~H~5~ (**1g**)      **3g**   24                                         72                                          \>99
  8       *p*-NO~2~C~6~H~5~ (**1h**)      **3h**   24                                         74                                          93
  9       *m*-MeC~6~H~5~ (**1i**)         **3i**   36                                         91                                          97
  10      *m*-ClC~6~H~5~ (**1j**)         **3j**   24                                         88                                          96
  11      *m*-NO~2~C~6~H~5~ (**1k**)      **3k**   30                                         95                                          95
  12      *o*-MeC~6~H~5~ (**1l**)         **3l**   48                                         trace                                        
  13      3,4-(OMe)~2~C~6~H~4~ (**1m**)   **3m**   48                                         78                                          \>99
  14      2-naphthyl (**1n**)             **3n**   24                                         98                                          \>99
  15      2-thienyl (**1o**)              **3o**   24                                         81                                          99
  16      2-furyl (**1p**)                **3p**   30                                         87                                          96

Unless otherwise noted, the reactions of **1** (0.2 mmol) and **2** (0.6 mmol) were performed in the presence of **L1** (10 mol %), Zn(OTf)~2~ (10 mol %), and piperidine (10 mol %) in H~2~O/CHCl~3~ (2.0/0.2 mL) at 0 °C for the time indicated.

Detemined by TLC detection.

Isolated yields.

Determined by chiral HPLC analysis.

To obtain insight into the reaction mechanism, several control experiments were carried out ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). First, the reaction of *N*-methylpyrrole with 2-enoyl-pyridine *N*-oxide **1a** was performed under standard conditions. However, no reaction was observed (entry 1). When the reaction of 2,4-dimethylpyrrole with 2-enoyl-pyridine *N*-oxide **1a** was carried out under standard conditions, the corresponding product **3q** could be obtained in 96% yield with 32% ee (entry 2). These experimental results indicated that the NH in pyrrole played a crucial role in the formation of the chiral center, perhaps due to the fact that this NH group promoted the formation of a hydrogen bond to direct the attack orientation (entries 1 and 2). On the other hand, when the hydrophobic ligand **L3** without the dimethylamino groups was examined instead of the ligand **L1** in this reaction, the desired product could be obtained in 19% yield with 43% ee. This experiment suggested that the dimethylamino groups on the ligand **L1**, which act as hydrophilic groups to promote the formation of the emulsion, favored this reaction in water (entry 3).

![Control Experiments--\
Unless otherwise noted, the reactions of **1a** (0.1 mmol) and substituted pyrrole (0.3 mmol) were performed in the presence of **L1** or **L3** (10 mol %), Zn(OTf)~2~ (10 mol %), and piperidine (10 mol %) in H~2~O/CHCl~3~ (1.0/0.1 mL) at 0 °C for 24 h.\
Isolated yields.\
Determined by chiral HPLC analysis.](ao9b04115_0007){#sch2}

On the basis of the control experiments and our previous mechanism study,^[@ref10]^ a plausible structure of the transition state was proposed ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). The hydrophilic dimethylamino groups were dissolved in the water phase, while the 2-enoyl-pyridine *N*-oxide was activated by chelating with a metal center in the catalyst complex, and the NH in pyrrole served as a hydrogen bond-donating group to direct the alkylation at the *si* face of the 2-enoyl-pyridine *N*-oxide, affording the corresponding product in *S*-configuration.

![Plausible Structure of the Transition State of Friedel--Crafts Alkylation of 2-Enoyl-pyridine *N*-Oxide with Pyrrole](ao9b04115_0006){#sch3}

Subsequently, to probe the practicability of this asymmetric addition in water/chloroform (10:1), a gram-scale experiment was carried out under standard conditions ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). To our delight, the desired product **3c** was obtained with 1.31 g quantity, 90% yield, and 96% ee.

![Asymmetric Friedel--Crafts Alkylation on a Gram Scale--\
Unless otherwise noted, the reactions of **1a** (5 mmol) and **2** (15 mmol) were performed in the presence of **L1** (10 mol %), Zn(OTf)~2~ (10 mol %), and piperidine (10 mol %) in H~2~O/CHCl~3~ (25/2.5 mL) at 0 °C for 24 h.\
Isolated yields.\
Determined by chiral HPLC analysis.](ao9b04115_0005){#sch4}

Conclusions {#sec3}
===========

In conclusion, Lewis acid-catalyzed asymmetric Friedel--Crafts alkylation of pyrrole with 2-enoyl-pyridine *N*-oxide in water/chloroform (10:1) was developed under mild reaction conditions. A series of Friedel--Crafts alkylation products were obtained with excellent enantioselectivities and high yields. Moreover, a gram scale of the asymmetric Friedel--Crafts alkylation in aqueous media could be achieved.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

^1^H NMR and ^13^C NMR were recorded on a Bruker-400 MHz spectrometer (^1^H NMR: 400 MHz; ^13^C NMR: 100 MHz) using TMS as an internal reference. The chemical shifts (δ) and coupling constants (*J*) were expressed in ppm and Hz, respectively. UV--Vis spectrophotometry was carried out on a Shimadzu UV-3000. HPLC analysis was carried out on an Agilent 1100 series HPLC with a multiple wavelength detector. Chiralpak AS-H, AD-H, and OD-H columns were purchased from Daicel Chemical Industries, Ltd. Optical rotations were measured on a PerkinElmer polarimeter (model 343). HRMS (ESI) was recorded on Waters Q-TOF Premier and Thermo Scientific LTQ Orbitrap XL Hybrid Ion Trap-Orbitrap mass spectrometers. Commercially available compounds were used without further purification. Solvents were purified according to the standard procedures, unless otherwise noted. Commercial pyrrole should be distilled for the use of the reactions. Ligands^[@cit9d],[@cit10b]^ and various 2-enoyl-pyridine *N*-oxides **2**([@ref11]) were prepared according to literature procedures.

General Procedures for Friedel--Crafts Alkylation of Pyrroles with 2-Enoyl-pyridine *N*-Oxides in Aqueous Media {#sec4.2}
---------------------------------------------------------------------------------------------------------------

A mixture of ligand **L1** (0.02 mmol) and Zn(OTf)~2~ (0.02 mmol) in water (2.0 mL) was stirred for 2 h under an ambient atmosphere, and then 2-enoyl-pyridine *N*-oxides **1** (0.2 mmol), CHCl~3~ (0.2 mL), and piperidine (0.02 mmol) were added. The resulting mixture was cooled to 0 °C. After 30 min, the corresponding pyrrole **2** (40 μL, 0.6 mmol) was added slowly using a syringe. After the reactions were finished (monitored by TLC), the organic phase was separated and evaporated in vacuo. Purification by column chromatography afforded Friedel--Crafts alkylation adducts.

Experimental Data of Friedel--Crafts Products {#sec4.3}
---------------------------------------------

### (*S*)-2-(3-Phenyl-3-(1*H*-pyrrol-2-yl)propanoyl)pyridine 1-Oxide (**3a**) {#sec4.3.1}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a light yellow solid (92% yield); mp = 110--111 °C; \[α\]~D~^25^ 5.6 (*c* = 1.00, THF, 96% ee); HPLC: Daicel Chiralpak OD-H; hexane/2-propanol = 90:10; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 240 nm; *t*~R~ = 35.82 min (minor); *t*~R~ = 41.78 min (major); ^1^H NMR (400 MHz, CDCl~3~): δ 8.60 (br s, 1H), 8.16 (d, *J* = 6.5 Hz, 1H), 7.36 (dd, *J* = 7.7, 2.2 Hz, 1H), 7.34--7.29 (m, 1H), 7.28--7.18 (m, 6H), 6.64--6.62 (m, 1H), 6.07 (dd, *J* = 5.8, 2.8 Hz, 1H), 5.92--5.90 (m, 1H), 4.73 (dd, *J* = 8.5, 6.5 Hz, 1H), 4.12 (dd, *J* = 17.1, 8.4 Hz, 1H), 3.69 (dd, *J* = 17.1, 6.5 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 196.5, 146.8, 143.0, 140.3, 133.6, 128.6, 127.9, 127.9, 126.8, 126.8, 126.0, 117.1, 108.1, 105.8, 48.6, 40.0; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~18~H~16~N~2~O~2~H, 293.1285; found, 293.1282.

### (*S*)-2-(3-(1*H*-Pyrrol-2-yl)-3-(*p*-tolyl)propanoyl)pyridine 1-Oxide (**3b**) {#sec4.3.2}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a light yellow solid (90% yield); mp = 135--136 °C; \[α\]~D~^25^ 1.6 (*c* = 0.90, THF, 94% ee); HPLC: Daicel Chiralpak AS-H; hexane/2-propanol = 70:30; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 240 nm; *t*~R~ = 20.51 min (major); *t*~R~ = 34.02 min (minor); ^1^H NMR (400 MHz, CDCl~3~): δ 8.56 (br s, 1H), 8.26--8.04 (m, 1H), 7.38--7.28 (m, 2H), 7.27--7.21 (m, 1H), 7.12--7.05 (m, 4H), 6.75--6.52 (m, 1H), 6.07 (dd, *J* = 5.8, 2.9 Hz, 1H), 5.95--5.81 (m, 1H), 4.77--4.58 (m, 1H), 4.10 (dd, *J* = 17.1, 8.4 Hz, 1H), 3.68 (dd, *J* = 17.1, 6.6 Hz, 1H), 2.29 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~): δ 196.6, 146.8, 140.3, 139.9, 136.3, 133.8, 129.3, 127.8, 127.8, 126.8, 125.9, 117.0, 108.1, 105.7, 48.7, 39.6, 21.0; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~19~H~18~N~2~O~2~H, 307.1441; found, 307.1434.

### (*S*)-2-(3-(4-Methoxyphenyl)-3-(1*H*-pyrrol-2-yl)propanoyl)pyridine 1-Oxide (**3c**) {#sec4.3.3}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a light yellow oil (84% yield); \[α\]~D~^25^ 2.0 (*c* = 1.05, THF, 98% ee); HPLC: Daicel Chiralpak AS-H; hexane/2-propanol = 70:30; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 230 nm; *t*~R~ = 39.68 min (major); *t*~R~ = 68.70 min (minor); ^1^H NMR (400 MHz, CDCl~3~): δ 8.57 (br s, 1H), 8.16 (d, *J* = 6.4 Hz, 1H), 7.37--7.29 (m, 2H), 7.26--7.21 (m, 1H), 7.18--7.09 (m, 2H), 6.83--6.74 (m, 2H), 6.64--6.59 (m, 1H), 6.10--6.03 (m, 1H), 5.91--5.87 (m, 1H), 4.67 (t, *J* = 7.5 Hz, 1H), 4.07 (dd, *J* = 17.0, 8.2 Hz, 1H), 3.76 (s, 3H), 3.67 (dd, *J* = 17.0, 6.8 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 196.6, 158.3, 146.8, 140.3, 135.0, 134.0, 128.9, 127.8, 126.8, 125.9, 117.0, 113.9, 108.0, 105.6, 55.3, 48.8, 39.2; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~19~H~18~N~2~O~3~H, 323.1390; found, 323.1394.

### (*S*)-2-(3-(4-Fluorophenyl)-3-(1*H*-pyrrol-2-yl)propanoyl)pyridine 1-Oxide (**3d**) {#sec4.3.4}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a light yellow oil (95% yield); \[α\]~D~^25^ 4.8 (*c* = 0.86, THF, 97% ee); HPLC: Daicel Chiralpak AS-H; hexane/2-propanol = 70:30; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 230 nm; *t*~R~ = 18.48 min (major); *t*~R~ = 30.44 min (minor); ^1^H NMR (400 MHz, CDCl~3~): δ 8.72 (br s, 1H), 8.15 (d, *J* = 6.6 Hz, 1H), 7.39 (dd, *J* = 7.8, 2.3 Hz, 1H), 7.36--7.30 (m, 1H), 7.28--7.23 (m, 1H), 7.22--7.13 (m, 2H), 6.95--6.91 (m, 2H), 6.67--6.60 (m, 1H), 6.07 (dd, *J* = 2.8 Hz, 1H), 5.95--5.77 (m, 1H), 4.72 (t, 1H), 4.09 (dd, *J* = 17.2, 8.4 Hz, 1H), 3.67 (dd, *J* = 17.2, 6.6 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 196.2, 162.8--160.4 (d, ^1^*J*~CF~ = 161.6 Hz), 146.7, 140.3, 138.8--138.8 (d, ^4^*J*~CF~ = 3.0 Hz), 133.4, 129.4--129.3 (d, ^3^*J*~CF~ = 8.0 Hz), 128.0, 126.8, 126.0, 117.3, 115.4--115.2 (d, ^2^*J*~CF~ = 21.3 Hz), 108.1, 105.9, 48.7, 39.2; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~18~H~15~FN~2~O~2~H, 311.1190; found, 311.1183.

### (*S*)-2-(3-(4-Chlorophenyl)-3-(1*H*-pyrrol-2-yl)propanoyl)pyridine 1-Oxide (**3e**) {#sec4.3.5}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a light yellow solid (88% yield); mp = 139--140 °C; \[α\]~D~^25^ 2.5 (*c* = 0.90, THF, 93% ee); HPLC: Daicel Chiralpak AS-H; hexane/2-propanol = 70:30; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 230 nm; *t*~R~ = 19.58 min (major); *t*~R~ = 34.73 min (minor); ^1^H NMR (400 MHz, CDCl~3~): δ 8.67 (br s, 1H), 8.18 (d, *J* = 6.0 Hz, 1H), 7.45 (dd, *J* = 7.9, 2.2 Hz, 1H), 7.41--7.32 (m, 1H), 7.29 (dd, *J* = 7.7, 1.2 Hz, 1H), 7.27--7.19 (m, 2H), 7.22--7.14 (m, 2H), 6.71--6.62 (m, 1H), 6.12--6.04 (m, 1H), 5.96--5.85 (m, 1H), 4.75--4.71 (m, 1H), 4.12 (dd, *J* = 17.3, 8.4 Hz, 1H), 3.66 (dd, *J* = 17.3, 6.5 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 196.0, 146.6, 141.6, 140.4, 133.0, 132.5, 129.3, 128.7, 128.0, 127.0, 126.0, 117.3, 108.2, 106.0, 48.5, 39.3; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~18~H~15~ClN~2~O~2~H, 327.0895; found, 327.0895.

### (*S*)-2-(3-(4-Bromophenyl)-3-(1*H*-pyrrol-2-yl)propanoyl)pyridine 1-Oxide (**3f**) {#sec4.3.6}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a light yellow oil (92% yield); \[α\]~D~^25^ 4.5 (*c* = 1.00, THF, \>99% ee); HPLC: Daicel Chiralpak AS-H; hexane/2-propanol = 70:30; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 230 nm; *t*~R~ = 24.46 min (major); ^1^H NMR (400 MHz, CDCl~3~): δ 8.67 (br s, 1H), 8.17 (d, *J* = 6.4 Hz, 1H), 7.44 (dd, *J* = 7.8, 2.2 Hz, 1H), 7.42--7.31 (m, 3H), 7.29 (dd, *J* = 7.7, 1.1 Hz, 1H), 7.16--7.07 (m, 2H), 6.68--6.61 (m, 1H), 6.12--6.04 (m, 1H), 5.95--5.83 (m, 1H), 4.71 (t, *J* = 14.8 Hz, 1H), 4.11 (dd, *J* = 17.3, 8.4 Hz, 1H), 3.66 (dd, *J* = 17.3, 6.5 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 196.0, 146.5, 142.1, 140.4, 132.9, 131.7, 129.7, 128.0, 127.0, 126.0, 120.6, 117.3, 108.2, 106.0, 48.4, 39.4; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~18~H~15~BrN~2~O~2~H, 371.0390; found, 371.0378.

### (*S*)-2-(3-(1*H*-Pyrrol-2-yl)-3-(4-(trifluoromethyl)phenyl)propanoyl)pyridine 1-oxide (**3g**) {#sec4.3.7}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a light yellow oil (72% yield); \[α\]~D~^25^ 14.8 (*c* = 0.89, THF, \>99% ee); HPLC: Daicel Chiralpak AS-H; hexane/2-propanol = 80:20; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 240 nm; *t*~R~ = 18.22 min (major); ^1^H NMR (400 MHz, CDCl~3~): δ 8.76 (br s, 1H), 8.20 (d, *J* = 6.4 Hz, 1H), 7.55--7.49 (m, 2H), 7.46 (dd, *J* = 7.8, 2.3 Hz, 1H), 7.41--7.34 (m, 3H), 7.32--7.27 (m, 1H), 6.74--6.59 (m, 1H), 6.19--6.04 (m, 1H), 5.96--5.82 (m, 1H), 4.82 (t, 1H), 4.17 (dd, *J* = 17.4, 8.6 Hz, 1H), 3.70 (dd, *J* = 17.4, 6.4 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 195.8, 147.2, 146.4, 140.4, 132.5, 132.4--122.8 (q, ^1^*J*~CF~ = 320.0 Hz), 129.2, 128.8, 128.7, 128.3, 128.3, 128.1, 127.0, 126.3, 125.6--125.5 (q, ^4^*J*~CF~ = 3.7 Hz), 117.5, 108.3, 106.3, 48.3, 39.7; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~18~H~15~F~3~N~2~O~2~H, 361.1158; found, 361.1157.

### (*S*)-2-(3-(4-Nitrophenyl)-3-(1*H*-pyrrol-2-yl)propanoyl)pyridine 1-Oxide (**3h**) {#sec4.3.8}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a light yellow oil (74% yield); \[α\]~D~^25^ 14.9 (*c* = 0.62, THF, 93% ee); HPLC: Daicel Chiralpak AS-H; hexane/2-propanol = 70:30; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 215 nm; *t*~R~ = 36.85 min (major); *t*~R~ = 48.81 min (minor); ^1^H NMR (400 MHz, CDCl~3~): δ 8.95 (br s, 1H), 8.19 (d, *J* = 6.5 Hz, 1H), 8.14--8.06 (m, 2H), 7.51 (dd, *J* = 7.9, 1.7 Hz, 1H), 7.46--7.35 (m, 3H), 7.31 (td, *J* = 7.7, 1.2 Hz, 1H), 6.71--6.61 (m, 1H), 6.14--6.02 (m, 1H), 5.97--5.87 (m, 1H), 4.89 (dd, *J* = 8.5, 6.3 Hz, 1H), 4.19 (dd, *J* = 17.6, 8.5 Hz, 1H), 3.71 (dd, *J* = 17.5, 6.3 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 195.3, 150.9, 146.7, 146.3, 140.5, 131.8, 128.8, 128.3, 127.1, 126.2, 123.8, 117.8, 108.4, 106.5, 48.0, 39.7; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~18~H~15~N~3~O~4~H, 338.1135; found, 338.1136.

### (*S*)-2-(3-(1*H*-Pyrrol-2-yl)-3-(*m*-tolyl)propanoyl)pyridine 1-Oxide (**3i**) {#sec4.3.9}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a light yellow oil (91% yield); \[α\]~D~^25^ 7.5 (*c* = 1.02, THF, 97% ee); HPLC: Daicel Chiralpak AS-H; hexane/2-propanol = 70:30; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 230 nm; *t*~R~ = 16.88 min (major); *t*~R~ = 28.21 min (minor); ^1^H NMR (400 MHz, CDCl~3~): δ 8.62 (br s, 1H), 8.15 (d, *J* = 6.5 Hz, 1H), 7.35--7.28 (m, 2H), 7.22 (td, *J* = 7.7, 1.2 Hz, 1H), 7.13 (t, *J* = 7.5 Hz, 1H), 7.07--6.90 (m, 3H), 6.67--6.57 (m, 1H), 6.11--6.01 (m, 1H), 5.99--5.84 (m, 1H), 4.76--4.62 (m, 1H), 4.10 (dd, *J* = 17.1, 8.7 Hz, 1H), 3.67 (dd, *J* = 17.1, 6.5 Hz, 1H), 2.27 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~): δ 196.6, 146.9, 142.9, 140.2, 138.2, 133.7, 128.6, 128.5, 127.8, 127.5, 126.8, 125.9, 124.9, 117.0, 108.1, 105.7, 48.5, 40.0, 21.4; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~19~H~18~N~2~O~2~H, 307.1441; found, 307.1441.

### (*S*)-2-(3-(3-Chlorophenyl)-3-(1*H*-pyrrol-2-yl)propanoyl)pyridine 1-Oxide (**3j**) {#sec4.3.10}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a light yellow oil (88% yield); \[α\]~D~^25^ 10.8 (*c* = 0.65, THF, 96% ee); HPLC: Daicel Chiralpak AS-H; hexane/2-propanol = 70:30; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 240 nm; *t*~R~ = 16.08 min (major); *t*~R~ = 24.62 min (minor); ^1^H NMR (400 MHz, CDCl~3~): δ 8.76 (br s, 1H), 8.17 (d, J = 6.5 Hz, 1H), 7.44--7.40 (m, 1H), 7.38--7.31 (m, 1H), 7.29--7.24 (m, 1H), 7.23--7.20 (m, 1H), 7.19--7.10 (m, 3H), 6.73--6.58 (m, 1H), 6.12--6.05 (m, 1H), 5.95--5.86 (m, 1H), 4.72 (dd, *J =* 8.6, 6.3 Hz, 1H), 4.12 (dd, *J =* 17.3, 8.6 Hz, 1H), 3.66 (dd, *J =* 17.3, 6.3 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 195.9, 146.6, 145.2, 140.4, 134.3, 132.7, 129.9, 128.0, 126.9, 126.9, 126.1, 126.0, 117.4, 108.2, 106.1, 48.3, 39.6; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~18~H~15~ClN~2~O~2~H, 327.0895; found, 314.0895.

### (*S*)-2-(3-(3-Nitrophenyl)-3-(1*H*-pyrrol-2-yl)propanoyl)pyridine 1-Oxide (**3k**) {#sec4.3.11}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a brown oil (95% yield); \[α\]~D~^25^ 15.1 (*c* = 0.80, THF, 95% ee); HPLC: Daicel Chiralpak AS-H; hexane/2-propanol = 70:30; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 254 nm; *t*~R~ = 26.16 min (major); *t*~R~ = 36.64 min (minor); ^1^H NMR (400 MHz, CDCl~3~): δ 8.97 (br s, 1H), 8.21 (d, *J* = 6.4 Hz, 1H), 8.15--8.01 (m, 2H), 7.61 (d, *J* = 7.7 Hz, 1H), 7.54--7.48 (m, 1H), 7.46--7.42 (m, 1H), 7.43--7.29 (m, 2H), 6.73--6.62 (m, 1H), 6.17--6.04 (m, 1H), 5.94--5.85 (m, 1H), 4.89 (t, *J* = 7.5 Hz, 1H), 4.21 (dd, *J* = 17.5, 8.5 Hz, 1H), 3.73 (dd, *J* = 17.5, 6.4 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 195.4, 148.3, 146.3, 145.5, 140.5, 134.3, 132.1, 129.6, 128.3, 127.1, 126.3, 122.8, 121.9, 117.8, 108.4, 106.5, 48.2, 39.6; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~18~H~15~N~3~O~4~H, 338.1135; found, 338.1130.

### (*S*)-2-(3-(3,4-Dimethoxyphenyl)-3-(1*H*-pyrrol-2-yl)propanoyl)pyridine 1-Oxide (**3m**) {#sec4.3.12}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a light yellow solid (78% yield); mp = 94--95 °C; \[α\]~D~^25^ 4.3 (*c* = 0.97, THF, \>99% ee); HPLC: Daicel Chiralpak AS-H; hexane/2-propanol = 70:30; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 230 nm; *t*~R~ = 30.76 min (major); ^1^H NMR (400 MHz, CDCl~3~): δ 8.55 (br s, 1H), 8.17 (d, *J* = 6.4 Hz, 1H), 7.39--7.31 (m, 2H), 7.28--7.22 (m, 1H), 6.81--6.73 (m, 3H), 6.66--6.61 (m, 1H), 6.13--6.05 (m, 1H), 5.96--5.87 (m, 1H), 4.67 (t, *J* = 7.5 Hz, 1H), 4.08 (dd, *J* = 17.0, 8.2 Hz, 1H), 3.83 (s, 3H), 3.79 (s, 3H), 3.72 (dd, *J* = 17.0, 6.9 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 196.6, 149.0, 147.8, 146.8, 140.3, 135.4, 133.8, 127.8, 126.8, 126.0, 119.9, 117.1, 111.1, 111.1, 108.1, 105.6, 55.9, 55.8, 48.7, 39.7; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~20~H~20~N~2~O~4~H, 353.1496; found, 353.1497.

### (*S*)-2-(3-(Naphthalen-2-yl)-3-(1*H*-pyrrol-2-yl)propanoyl)pyridine 1-Oxide (**3n**) {#sec4.3.13}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a light yellow oil (98% yield); \[α\]~D~^25^ −5.2 (*c* = 0.90, THF, 99% ee); HPLC: Daicel Chiralpak AS-H; hexane/2-propanol = 70:30; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 240 nm; *t*~R~ = 26.02 min (minor); *t*~R~ = 31.30 min (major); ^1^H NMR (400 MHz, CDCl~3~): δ 8.66 (br s, 1H), 8.12 (d, *J* = 6.4 Hz, 1H), 7.79--7.70 (m, 3H), 7.69--7.66 (m, 1H), 7.47--7.39 (m, 2H), 7.34 (td, *J* = 8.4, 2.0 Hz, 2H), 7.29--7.21 (m, 1H), 7.19--7.12 (m, 1H), 6.69--6.59 (m, 1H), 6.12--6.08 (m, 1H), 5.99--5.93 (m, 1H), 4.90 (dd, *J* = 8.3, 6.6 Hz, 1H), 4.20 (dd, *J* = 17.2, 8.3 Hz, 1H), 3.81 (dd, *J* = 17.2, 6.6 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 196.4, 146.7, 140.4, 140.3, 133.5, 133.4, 132.4, 128.4, 127.8, 127.8, 127.6, 126.8, 126.4, 126.2, 126.1, 125.9, 125.7, 117.3, 108.2, 106.0, 48.4, 40.1; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~22~H~18~N~2~O~2~H, 343.1441; found, 343.1436.

### (*S*)-2-(3-(1*H*-Pyrrol-2-yl)-3-(thiophen-2-yl)propanoyl)pyridine 1-Oxide (**3o**) {#sec4.3.14}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a light yellow oil (81% yield); \[α\]~D~^25^ 4.9 (*c* = 0.48, THF, 94% ee); HPLC: Daicel Chiralpak AD-H; hexane/2-propanol = 70:30; flow rate = 0.8 mL/min; *T* = 30 °C; UV = 240 nm; *t*~R~ = 10.96 min (minor); *t*~R~ = 10.22 min (major); ^1^H NMR (400 MHz, CDCl~3~): δ 8.69 (br s, 1H), 8.16 (d, *J* = 6.4 Hz, 1H), 7.41 (dd, *J* = 7.8, 2.2 Hz, 1H), 7.37--7.30 (m, 1H), 7.30--7.21 (m, 1H), 7.12 (dd, *J* = 4.9, 1.4 Hz, 1H), 6.91--6.84 (m, 2H), 6.68--6.57 (m, 1H), 6.12--6.06 (m, 1H), 6.02--5.95 (m, 1H), 5.03 (t, *J* = 0.3 Hz, 1H), 4.14 (dd, *J* = 17.1, 8.1 Hz, 1H), 3.79 (dd, *J* = 17.1, 6.8 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 195.8, 146.7, 146.7, 140.3, 133.0, 128.0, 126.9, 126.7, 125.9, 124.6, 124.1, 117.2, 108.2, 105.8, 49.6, 35.4; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~16~H~14~N~2~O~2~SH, 299.0849; found, 299.0848.

### (*S*)-2-(3-(Furan-2-yl)-3-(1*H*-pyrrol-2-yl)propanoyl)pyridine 1-Oxide (**3p**) {#sec4.3.15}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a light yellow oil (87% yield); \[α\]~D~^25^ 5.5 (*c* = 0.50, THF, 96% ee); HPLC: Daicel Chiralpak AD-H; hexane/2-propanol = 90:10; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 240 nm; *t*~R~ = 38.38 min (major); *t*~R~ = 45.02 min (minor); ^1^H NMR (400 MHz, CDCl~3~): δ 8.79 (br s, 1H), 8.32--8.13 (m, 1H), 7.45 (dd, *J* = 7.8, 1.7 Hz, 1H), 7.36--7.31 (m, 1H), 7.28--7.27 (m, 1H), 7.26--7.23 (m, 1H), 6.70--6.61 (m, 1H), 6.29--6.23 (m, 1H), 6.11--6.03 (m, 2H), 5.97--5.92 (m, 1H), 4.83 (t, *J* = 7.3 Hz, 1H), 4.02 (dd, *J* = 17.2, 8.1 Hz, 1H), 3.79 (dd, *J* = 17.2, 6.7 Hz, 1H). ^13^C NMR (100 MHz, CDCl~3~): δ 195.8, 155.5, 146.5, 141.5, 140.4, 131.0, 128.0, 126.9, 125.8, 117.2, 110.2, 108.1, 105.8, 105.8, 46.9, 33.9; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~16~H~14~N~2~O~3~H, 283.1077; found, 283.1075.

### (*S*)-2-(3-(3,5-Dimethyl-1*H*-pyrrol-2-yl)-3-phenylpropanoyl)pyridine 1-Oxide (**3q**) {#sec4.3.16}

The title compound was prepared according to the general working procedure and purified by column chromatography (ethyl acetate = 1) to give the product as a yellow oil (96% yield); \[α\]~D~^25^ 0.2 (*c* = 1.0, THF, 32% ee); HPLC: Daicel Chiralpak OD-H; hexane/2-propanol = 90:10; flow rate = 1.0 mL/min; *T* = 30 °C; UV = 230 nm; *t*~R~ = 20.08 min (minor); *t*~R~ = 27.52 min (major); ^1^H NMR (400 MHz, CDCl~3~): δ 8.71 (br s, 1H), 8.15 (d, *J* = 6.3 Hz, 1H), 7.38--7.27 (m, 1H), 7.27--7.19 (m, 6H), 7.17--7.12 (m, 1H), 5.57 (d, *J* = 2.7 Hz, 1H), 4.75 (dd, *J* = 9.9, 6.3 Hz, 1H), 4.21 (dd, *J* = 16.3, 9.9 Hz, 1H), 3.54 (dd, *J* = 16.3, 6.3 Hz, 1H), 2.11 (s, 3H), 1.87 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~): δ 196.7, 146.7, 145.3, 143.4, 140.0, 128.6, 127.7, 127.3, 126.6, 126.5, 126.3, 125.8, 114.9, 107.9, 46.9, 38.5, 13.0, 11.0; HRMS (ESI-TOF) *m*/*z*: \[M + H\]^+^ calcd for C~20~H~20~N~2~O~2~H, 321.1598; found, 321.1594.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.9b04115](https://pubs.acs.org/doi/10.1021/acsomega.9b04115?goto=supporting-info).^1^H NMR and ^13^C NMR spectra for all the products along with HPLC profiles ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b04115/suppl_file/ao9b04115_si_001.pdf))
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